Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 16
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The worm that must be named: Schikhobalotrema n.sp.

    Trematodes are a highly diverse group of parasitic flatworms with complex multi-host life-cycles. I’ve collected...

    Creating a Genetic Circuit Control Toolbox

    Synthetic biology studies the design of genetic circuits to program cells to solve problems in areas like medicine...

    Backer Badge Funded